Get started
Award

Gilead_IN-IT-989

Funded outputs count: 15
Funder award ID: Gilead_IN-IT-989
OpenAlex ID: G7623918730
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease
2024 · Oveis Jamialahmadi, Antonio De Vincentis, et al. · Nature Medicine · 141
PDF
The contribution of genetics and epigenetics to MAFLD susceptibility
2024 · Vittoria Moretti, Stefano Romeo, et al. · Hepatology International · 42
PDF
Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD
2024 · Serena Pelusi, Luisa Ronzoni, et al. · Clinical Gastroenterology and Hepatology · 15
PDF
Estrogen–ER‐α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women
2024 · Alessandro Cherubini, Elia Casirati, et al. · Clinical and Translational Medicine · 4
PDF
Predictors of controlled attenuation parameter in metabolic dysfunction
2023 · Cristiana Bianco, Serena Pelusi, et al. · United European Gastroenterology Journal · 13
PDF
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
2023 · Alessandro Cherubini, Mahnoosh Ostadreza, et al. · Nature Medicine · 135
PDF
The genetics of portal hypertension: Recent developments and the road ahead
2023 · Sarah Shalaby, Luisa Ronzoni, et al. · Liver International · 13
PDF
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH
2023 · Mary Patricia Moore, Xiaobo Wang, et al. · JHEP Reports · 15
PDF
Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death
2022 · G. Assante, A. Tourna, et al. · Scientific Reports · 7
PDF
Rare ATG7 genetic variants predispose patients to severe fatty liver disease
2022 · Guido A. Baselli, Oveis Jamialahmadi, et al. · Journal of Hepatology · 96
PDF
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
2021 · Hamish Innes, Hans Dieter Nischalke, et al. · Hepatology Communications · 24
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date
2021 · Alessandro Cherubini, Elia Casirati, et al. · Expert Opinion on Therapeutic Targets · 79
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real‐Life Cohort Study
2021 · Luca Valenti, Serena Pelusi, et al. · Hepatology Communications · 15
PDF
Is there an ‘ideal’ diet for patients with NAFLD?
2021 · Nicola Pugliese, Maria Corina Plaz Torres, et al. · European Journal of Clinical Investigation · 65
PDF
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders”
2021 · Elena Corradini, Luca V. Valenti · Journal of Hepatology · 2
Year
Topic